CARO PHARMA: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
CARO PHARMA
Largest movements
- Intangible fixed assets -€68,799
down €68,799 (-16.7%), from €412,517 to €343,718
- Tangible fixed assets -€9,755
down €9,755 (-6.4%), from €152,449 to €142,694
of which Land and buildings: -€8,100
- Debts after one year -€69,029
down €69,029 (-28.2%), from €244,674 to €175,645
of which Financial debts: -€47,206
- Profit (loss) carried forward -€26,056
down €26,056 (-20.8%), from €125,325 to €99,269
- Tax, wage and social debts +€16,786
up €16,786 (+88.7%), from €18,915 to €35,702
- Taxes -€63,052
down €63,052 (-79.3%), from €79,510 to €16,459
- Gross operating margin -€10,052
down €10,052 (-11.0%), from €91,505 to €81,453
- Financial charges -€2,798
down €2,798 (-20.6%), from €13,589 to €10,792
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €669,636 | €593,057 | -€76,579 | -11.4% |
| Fixed assets | 21/28 | €564,966 | €486,412 | -€78,554 | -13.9% |
| Intangible fixed assets | 21 | €412,517 | €343,718 | -€68,799 | -16.7% |
| Tangible fixed assets | 22/27 | €152,449 | €142,694 | -€9,755 | -6.4% |
| Land and buildings | 22 | €150,081 | €141,981 | -€8,100 | -5.4% |
| Plant, machinery and equipment | 23 | €1,331 | €713 | -€618 | -46.4% |
| Furniture and vehicles | 24 | €1,036 | - | -€1,036 | |
| Current assets | 29/58 | €104,670 | €106,645 | +€1,975 | +1.9% |
| Stocks and contracts in progress | 3 | €38,640 | €38,477 | -€163 | -0.4% |
| Stocks | 30/36 | €38,640 | €38,477 | -€163 | -0.4% |
| Amounts receivable within one year | 40/41 | €35,279 | €34,318 | -€961 | -2.7% |
| Trade receivables | 40 | €35,279 | €34,318 | -€961 | -2.7% |
| Cash at bank and in hand | 54/58 | €26,783 | €29,891 | +€3,107 | +11.6% |
| Deferred charges and accrued income | 490/1 | €3,967 | €3,959 | -€8 | -0.2% |
| Total equity and liabilities | 10/49 | €669,636 | €593,057 | -€76,579 | -11.4% |
| Equity | 10/15 | €180,325 | €154,269 | -€26,056 | -14.4% |
| Contributions | 10/11 | €50,000 | €50,000 | = | 0.0% |
| Reserves | 13 | €5,000 | €5,000 | = | 0.0% |
| Distributable reserves | 133 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €125,325 | €99,269 | -€26,056 | -20.8% |
| Provisions and deferred taxes | 16 | €100,483 | €99,034 | -€1,449 | -1.4% |
| Provisions for liabilities and charges | 160/5 | €71,027 | €71,027 | = | 0.0% |
| Pensions and similar obligations | 160 | €71,027 | €71,027 | = | 0.0% |
| Deferred taxes | 168 | €29,456 | €28,007 | -€1,449 | -4.9% |
| Amounts payable | 17/49 | €388,828 | €339,754 | -€49,074 | -12.6% |
| Amounts payable after more than one year | 17 | €244,674 | €175,645 | -€69,029 | -28.2% |
| Financial debts | 170/4 | €112,894 | €65,688 | -€47,206 | -41.8% |
| Other amounts payable | 178/9 | €131,780 | €109,957 | -€21,823 | -16.6% |
| Amounts payable within one year | 42/48 | €136,622 | €151,494 | +€14,872 | +10.9% |
| Current portion of amounts payable after more than one year | 42 | €44,701 | €46,107 | +€1,405 | +3.1% |
| Trade debts | 44 | €73,005 | €69,686 | -€3,319 | -4.5% |
| Suppliers | 440/4 | €73,005 | €69,686 | -€3,319 | -4.5% |
| Taxes, remuneration and social security | 45 | €18,915 | €35,702 | +€16,786 | +88.7% |
| Taxes | 450/3 | €18,915 | €35,702 | +€16,786 | +88.7% |
| Accrued charges and deferred income | 492/3 | €7,532 | €12,614 | +€5,082 | +67.5% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €78,980 | €78,946 | -€34 | 0.0% |
| Other operating charges | 640/8 | €2,864 | €2,957 | +€93 | +3.2% |
| Gross operating margin | 9900 | €91,505 | €81,453 | -€10,052 | -11.0% |
| Operating profit (loss) | 9901 | €9,661 | -€450 | -€10,111 | |
| Financial income | 75/76B | - | €196 | +€196 | |
| Recurring financial income | 75 | - | €196 | +€196 | |
| Financial charges | 65/66B | €13,589 | €10,792 | -€2,798 | -20.6% |
| Recurring financial charges | 65 | €13,589 | €10,792 | -€2,798 | -20.6% |
| Profit (loss) for the period before taxes | 9903 | -€3,929 | -€11,046 | -€7,117 | -181% |
| Transfer from deferred taxes | 780 | €1,449 | €1,449 | = | 0.0% |
| Income taxes | 67/77 | €79,510 | €16,459 | -€63,052 | -79.3% |
| Profit (loss) for the period | 9904 | -€81,990 | -€26,056 | +€55,935 | +68.2% |
| Profit (loss) for the period to be appropriated | 9905 | -€81,990 | -€26,056 | +€55,935 | +68.2% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 26 October 2026 via checked.be.